Ortega González E, Domínguez-Hernández R, Martínez Roma M, Ocete-Mochone MD, Carrodeguas A, González-Sánchez JL, Casado MA, García Deltoro M

Ortega González E, Domínguez-Hernández R, Martínez Roma M, Ocete-Mochone MD, Carrodeguas A, González-Sánchez JL, Casado MA, García Deltoro M

 

Value of public health interventions for HIV, HBV and HCV integrated screening: The FOCUS-CRIVALVIR programme
Ann Epidemiol. 2025;109:31-37. doi: 10.1016/j.annepidem.2025.06.014

Gil-Prieto R, Pérez-Martín J, Díaz Aguiló A, Soudani S, Platero-Alonso L, López-Belmonte JL, de la Cuadra-Grande A, Casado MA, Alvarez Aldean J

 

 

Estimating the economically justifiable price of nirsevimab vs. Standard of Practice for the prevention of respiratory syncytial virus infections in neonates and infants in Spain: A cost-utility modeling study
BMJ Public Health. 2025;3(2):e002441. doi: 10.1136/bmjph-2024-002441

Harper DM, Navarro-Alonso JA, Bosh FX, Paavonen J, Stanley M, Sasieni P, Yébenes M, Martínez-Martínez N, Rodríguez A, García A, Martín-Gómez L, Vallejo-Aparicio L, Carrión H, Ruiz García Y

 

Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: A systematic literature review.
Hum Vaccin Immunother. 2025 (1):2497608. doi: 10.1080/21645515.2025.2497608

Gómez-Peralta F, Robles-Plaza M, Mezquita-Raya P, Hernández AM, Cebrián-Cuenca A, Carretero J, Bellido V, Ampudia-Blasco FJ

 

 

Clinical and Economic Value of Flash Glucose Monitoring Systems in the Management of People with Type 2 Diabetes Mellitus on Basal Insulin and Poor Glycemic Control
85th Scientific Sessions – American Diabetes Association (ADA). Chicago. 20-30 jun 2025

Ampudia-Blasco FJ, Oyagüez I, Mezquita-Raya P, Hernández AM, Cebrián-Cuenca A, Carretero J, Bellido V, Gómez-Peralta F

 

 

Cost Analysis of FreeStyle Libre® Systems in Patients with Type 2 Diabetes Receiving Basal Insulin and Poor Glycemic Control (HbA1c > 8%): A Societal Perspective in Spain
85th Scientific Sessions – American Diabetes Association (ADA). Chicago. 20-30 jun 2025

Paladio-Duran N, Salinas-Ortega L, de la Cuadra-Grande A, Oyagüez I

 

 

Cost-effectiveness analysis of voclosporin vs mycophenolate or belimumab in the treatment of patients with lupus nephritis from the Spanish National Healthcare System perspective
62nd European Renal Association (ERA) Congress. Viena. 4-7 jun 2025

POSTER

Zaragoza R, Estella A, Nuvials X, Robles M, Casado A

 

 

Encuesta nacional a intensivistas sobre el manejo de infecciones fúngicas invasivas (IFI) en pacientes críticamente enfermos
XXVIII Congreso nacional SEIMC (Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica). Málaga. 22-24 may 2025

Buti M, Cabezas J, Domínguez-Hernández R, Cantero H, Casado MA

 

 

Socioeconomic Impact of Chronic Delta Hepatitis in Spain: Indirect Costs of Work Absenteeism, Presenteeism, and Premature Mortality
PLoS One. 2025;20(6):e0324834. doi: 10.1371/journal.pone.0324834

Cabezas J, Aguilera A, García F, Domínguez-Hernández R, Casado-Gómez A, Espinoza-Cámac N, Casado MA, Crespo J. On behalf of Task force Spanish Group for com-prehensive hepatitis diagnosis

 

Comprehensive diagnosis of viral hepatitis in Spain: Bases for implementation
Viruses. 2025;17(5):667. doi: 10.3390/v17050667

Fuentes A, Estévez-Escobar M, De Salazar A, Ruiz Escolano E ,Montiel N, Macías M, Alados JC, Aguilar JC, Pérez AB, Barrera Baena P, Cabezas T, Camelo-Castillo A, Palop B, González Grande R, Viciana I, Pinazo JM Bandera, Fernández Sánchez F, Lozano MC, Giráldez A, Domínguez MC, Jimeno Maté C, Ramírez Arellano E, Cordero P, Franco Álvarez De Luna F, del Pino P, De la Iglesia Salgado A, Pérez D, Sampedro A, López Garrido MA, Luzón-García MP, Salas-Coronas J, Roldán C, García F, Freyre C, Santamaría Rodríguez G, Rosales-Zabal JM, Domínguez-Hernández R, Casado MA, García F

Double reflex testing improvesthe efficacy and cost effectivenessof hepatitis delta diagnosis insouthern Spain
Sci Rep. 2025 May 2;15(1):15413